This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: The University of Hong Kong. Active years: 2010-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2017
Title: Innovations in Cancer Treatment by Raymond Wai-Yin Sun
Introduction
Raymond Wai-Yin Sun is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of pharmaceutical sciences, particularly in cancer treatment. With a total of three patents to his name, his work focuses on innovative compositions that aim to combat cancer effectively.
Latest Patents
One of his latest patents is a pharmaceutical composition containing cyclometalated N-heterocyclic carbene complexes for cancer treatment. This composition includes a cyclometalated N-heterocyclic carbene complex that contains either a gold(III) or a platinum(II) atom. The pharmaceutical composition exhibits anti-cancer activity, which includes the induction of cell death, inhibition of cellular proliferation, and the inhibition and poisoning of topoisomerase.
Career Highlights
Raymond Wai-Yin Sun is affiliated with The University of Hong Kong, where he conducts research and develops his innovative pharmaceutical compositions. His work has garnered attention for its potential to improve cancer treatment outcomes.
Collaborations
He collaborates with esteemed colleagues such as Chi Ming Che and Lok Fung Chow, contributing to a dynamic research environment focused on advancing cancer therapies.
Conclusion
Raymond Wai-Yin Sun's innovative work in developing pharmaceutical compositions for cancer treatment highlights his commitment to improving healthcare through scientific research. His contributions are paving the way for more effective cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile